Ovarian reserve - the quantity and quality of remaining eggs - is the central determinant of female fertility potential and declines with age. Anti-Mullerian hormone (AMH), measured by a simple blood test, provides the most sensitive clinical assessment of ovarian reserve, with levels below 1.0 ng/mL indicating diminished ovarian reserve (DOR) and below 0.5 ng/mL indicating significantly reduced reserve. While no intervention can create new eggs from scratch, targeted supplementation has shown meaningful capacity to improve the quality of remaining eggs, optimize the ovarian environment, and improve IVF outcomes in women with DOR.
DHEA: The Most Evidence-Backed DOR Intervention
DHEA (dehydroepiandrosterone) was first used for diminished ovarian reserve by Dr. Norbert Gleicher at the Center for Human Reproduction in New York, following an accidental self-experiment by a patient that dramatically improved her IVF outcome. Since then, multiple prospective trials and meta-analyses have evaluated DHEA supplementation before IVF in women with DOR.
DHEA improves ovarian reserve through several mechanisms: it is a precursor substrate for androgen synthesis in follicular theca cells, and intraovarian androgens are essential for early follicular development. Low androgens in the ovarian microenvironment impair the FSH response of granulosa cells, reducing follicular development. By raising androgen levels specifically in the ovary, DHEA improves follicular sensitivity to FSH stimulation.
A 2021 meta-analysis of 8 RCTs found DHEA supplementation significantly improved clinical pregnancy rates, AMH levels, antral follicle count, and reduced miscarriage rates in women with DOR undergoing IVF. The standard protocol is 25-75 mg of micronized DHEA daily for 3-6 months before IVF stimulation. Test baseline DHEA-S before supplementing (target the upper third of the normal range for age).
CoQ10: Mitochondrial Rescue of Remaining Eggs
CoQ10's role in egg quality is covered extensively in the CoQ10 fertility article, but it deserves emphasis in the DOR context. Women with DOR not only have fewer eggs but also older eggs that are more susceptible to mitochondrial dysfunction. CoQ10 at 600 mg of ubiquinol daily (the active reduced form) addresses the mitochondrial energy deficit that causes chromosomally abnormal eggs, potentially improving the quality of the limited eggs available in DOR patients.
The combination of DHEA and CoQ10 is the most commonly used protocol in reproductive endocrinology for DOR patients, with complementary mechanisms: DHEA addresses follicular quantity and responsiveness while CoQ10 addresses egg quality within developing follicles. Start both 3-6 months before IVF stimulation.
Melatonin: Follicular Fluid Antioxidant
Melatonin is not only a sleep hormone - it is a potent antioxidant concentrated in follicular fluid surrounding developing eggs. Reactive oxygen species (ROS) generated during follicular growth damage oocyte DNA and mitochondria. Melatonin scavenges ROS specifically at the site of follicular development.
Several RCTs in IVF patients have found that melatonin supplementation (3 mg at bedtime, starting 1-2 months before egg retrieval) improves fertilization rates and embryo quality, particularly in women who had poor responses in previous IVF cycles. A Japanese trial found melatonin significantly increased the proportion of mature (MII) eggs and top-quality embryos. For DOR patients, melatonin at 3 mg nightly represents a safe, evidence-based addition to the protocol.
Vitamin D: AMH and Follicular Development
Vitamin D receptors are expressed in ovarian granulosa cells, and vitamin D participates in AMH signaling and follicular development. Multiple studies have found a positive correlation between serum vitamin D levels and AMH - women with higher vitamin D consistently have higher AMH levels in cross-sectional data.
A prospective study found that vitamin D repletion in deficient women significantly increased AMH levels over 6 months. While AMH reflects follicular quantity (which cannot be increased), optimizing vitamin D maximizes the function of remaining follicles. Target serum 25-OH vitamin D of 50-70 ng/mL through supplementation (typically 3,000-5,000 IU D3 daily for deficient women).
Myo-Inositol: FSH Sensitivity in DOR
Even in women without PCOS, myo-inositol supports granulosa cell insulin and FSH signaling. Women with DOR undergoing IVF often require very high doses of FSH to achieve adequate follicular development - inositol may improve follicular sensitivity to FSH, potentially reducing the dose of expensive injectable medications needed. 4 grams daily (as Ovasitol or equivalent myo-inositol + D-chiro-inositol 40:1 product) in the months before IVF is a low-risk adjunct with supporting pilot data.
FAQ
Can supplements increase AMH levels? Vitamin D repletion has been shown to increase AMH in deficient women, and DHEA has been shown to increase AMH in DOR patients in clinical trials. These are meaningful findings, though AMH still primarily reflects underlying ovarian reserve rather than egg quality.
How is a DOR supplement protocol structured? A typical integrative protocol for DOR: DHEA 25-75 mg daily + CoQ10 600 mg ubiquinol daily + melatonin 3 mg at bedtime + vitamin D to achieve 50-70 ng/mL + myo-inositol 4 g daily + omega-3 2-3 g daily. Begin 3-6 months before IVF stimulation. Always coordinate with your reproductive endocrinologist.
Should I take DHEA if I have PCOS and DOR? PCOS and DOR are unusual as a combination. Women with PCOS already have elevated androgens; adding DHEA could worsen androgen excess and metabolic dysfunction. DHEA for DOR is specifically intended for women with low-normal DHEA-S. Test levels and discuss with your reproductive endocrinologist before starting.
Related Articles
- AHCC: Immune Mushroom Extract for HPV and Cervical Health
- Best Supplements for Women Over 40
- Calcium for PMS: Why It's the Most Evidence-Based Supplement
- Choline in Pregnancy: The Overlooked Essential Nutrient
- CoQ10 for Egg Quality: The Mitochondrial Connection
Track your supplements in Optimize.
Related Supplement Interactions
Learn how these supplements interact with each other
Vitamin D3 + Magnesium
Vitamin D3 and Magnesium share a deeply interconnected metabolic relationship. Magnesium is a requir...
Omega-3 + Vitamin D3
Omega-3 fatty acids and Vitamin D3 are among the most commonly recommended supplements worldwide, an...
Calcium + Iron
Calcium and Iron have a well-documented competitive absorption interaction that can significantly re...
Calcium + Magnesium
Calcium and Magnesium are two of the most abundant minerals in the body and both play critical roles...
Related Articles
More evidence-based reading
Black Cohosh for Menopause: Evidence Review and Safety
A complete evidence review of black cohosh for menopause — mechanism, dosing, safety, liver concerns, and comparison to HRT.
6 min read →Women's HealthBlack Cohosh for Menopause: Benefits, Dosing, and Safety
A complete guide to black cohosh for menopause including clinical evidence, correct dosing, side effects, and how it compares to HRT.
4 min read →Women's HealthCalcium for PMS: Why It's the Most Evidence-Based Supplement
Four RCTs including a 466-woman multicenter trial confirm calcium at 1200mg reduces PMS by 48%. The calcium-calcitriol-PTH cycle explains the mechanism.
6 min read →